Literature DB >> 8164298

Effect of enteral feeding on hepatic steatosis induced by total parenteral nutrition.

O Zamir1, M S Nussbaum, S Bhadra, M T Subbiah, J F Rafferty, J E Fischer.   

Abstract

This study was designed to test the hypothesis that deprivation of enteral feeding contributes to the development of total parenteral nutrition (TPN)-induced hepatic dysfunction and that alterations of gut hormones are involved in its pathogenesis. Twenty-one adult Sprague-Dawley rats were randomized into three groups: group 1 received chow feeding ad libitum (288 kcal/kg per day); group 2 received dextrose-based TPN (320 +/- 5 kcal/kg per day); and group 3 received TPN (315 +/- 15 kcal/kg per day) plus chow feeding ad libitum (74 +/- 1 kcal/kg per day). After 7 days, portal blood was assayed for insulin, glucagon, gastrin, peptide YY, secretin, and vasoactive intestinal polypeptide; systemic blood for determination of liver function tests and serum lipid analysis. Liver biopsies were taken for histology and staining for fat, and the remainder of the livers were removed for tissue lipid analysis. TPN induced striking hepatic steatosis with prominent histologic changes and accumulation of lipids, mainly triglycerides and cholesterol ester, in the liver. Addition of enteral feeding to TPN-treated animals significantly reduced the histologic changes as well as lipid accumulation in the liver. Portal plasma levels of gastrin and peptide YY were reduced in animals maintained on TPN alone, with no change in secretin or vasoactive intestinal polypeptide levels. Enteral supplementation increased peptide YY levels in group 3, but not to normal, while gastrin secretion remained decreased. The serum triglyceride levels were decreased in both TPN groups; no differences were detected in the serum cholesterol levels or liver function tests.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8164298     DOI: 10.1177/014860719401800120

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  9 in total

1.  Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury.

Authors:  Mark Puder; Clarissa Valim; Jonathan A Meisel; Hau D Le; Vincent E de Meijer; Elizabeth M Robinson; Jing Zhou; Christopher Duggan; Kathleen M Gura
Journal:  Ann Surg       Date:  2009-09       Impact factor: 12.969

2.  Lipid deposition in Kupffer cells after parenteral fat nutrition in rats: a biochemical and ultrastructural study.

Authors:  B Roth; M Fkelund; B G Fan; I Hägerstrand; P Nilsson-Ehle
Journal:  Intensive Care Med       Date:  1996-11       Impact factor: 17.440

3.  Enteral bile acid treatment improves parenteral nutrition-related liver disease and intestinal mucosal atrophy in neonatal pigs.

Authors:  Ajay Kumar Jain; Barbara Stoll; Douglas G Burrin; Jens J Holst; David D Moore
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-11-17       Impact factor: 4.052

4.  The administration of ghrelin improved hepatocellular injury following parenteral feeding in a rat model of short bowel syndrome.

Authors:  Shun Onishi; Tatsuru Kaji; Waka Yamada; Kazuhiko Nakame; Tomoe Moriguchi; Koushirou Sugita; Koji Yamada; Takafumi Kawano; Motoi Mukai; Masakazu Souda; Sohsuke Yamada; Takako Yoshioka; Akihide Tanimoto; Satoshi Ieiri
Journal:  Pediatr Surg Int       Date:  2016-09-20       Impact factor: 1.827

5.  Low-fat, high-carbohydrate parenteral nutrition (PN) may potentially reverse liver disease in long-term PN-dependent infants.

Authors:  Marianne Skytte Jakobsen; Marianne Hørby Jørgensen; Steffen Husby; Leis Andersen; Palle Bekker Jeppesen
Journal:  Dig Dis Sci       Date:  2014-08-09       Impact factor: 3.199

6.  A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet.

Authors:  T A Byrne; R L Persinger; L S Young; T R Ziegler; D W Wilmore
Journal:  Ann Surg       Date:  1995-09       Impact factor: 12.969

7.  Persistent alanine aminotransferase elevations in children with parenteral nutrition-associated liver disease.

Authors:  Chi-Fu Jeffrey Yang; Michele Lee; Clarissa Valim; Melissa A Hull; Jing Zhou; Brian A Jones; Kathy Gura; Sharon Collier; Clifford Lo; Christopher Duggan; Tom Jaksic
Journal:  J Pediatr Surg       Date:  2009-06       Impact factor: 2.545

8.  Liver dysfunction associated with artificial nutrition in critically ill patients.

Authors:  Teodoro Grau; Alfonso Bonet; Mercedes Rubio; Dolores Mateo; Mercé Farré; José Antonio Acosta; Antonio Blesa; Juan Carlos Montejo; Abelardo García de Lorenzo; Alfonso Mesejo
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

Review 9.  Prevention and Treatment of Intestinal Failure-Associated Liver Disease in Children.

Authors:  Lorenzo Norsa; Emanuele Nicastro; Angelo Di Giorgio; Florence Lacaille; Lorenzo D'Antiga
Journal:  Nutrients       Date:  2018-05-24       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.